Thank You For Your Participation!

We appreciate your commitment to improving patient care through our clinical trial eligibility survey. Your input helps us determine if referred patients are eligible for enrollment in our Faricimab DME study.

Your responses will be carefully reviewed by our team of experts. If the patient meets the criteria, we’ll reach out to discuss enrollment options and provide further details about the trial.